BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Innovation, Insight and Education Focus of Day One of the 2009 Biotechnology Industry Organization (BIO) International Convention

  May 19, 2009

   · 

  1 min read
• Biotech Beach

  Life Technologies Corporation Announces Presentations at 2009 Biotechnology Industry Organization (BIO) International Convention

  May 19, 2009

   · 

  1 min read
• Pharm Country

  CardioNet, Inc. Announces that Highmark Medicare Services Posts Reimbursement Rate for CPT Code 93229, Mobile Cardiovascular Telemetry Services

  May 19, 2009

   · 

  1 min read
• Pharm Country

  SensiVida Medical Technologies, Inc. New Experienced, Successful Corporate Management Team Announces a 10 for 1 Reverse Stock Split with New Symbol SVMT

  May 19, 2009

   · 

  1 min read
• Pharm Country

  Merck & Co., Inc. to Launch TREDAPTIVE(TM) (ER niacin/laropiprant) in International Markets Later This Year

  May 19, 2009

   · 

  1 min read
• BioForest

  Cell Therapeutics, Inc. Amends ‘Modified Dutch Auction’ Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes

  May 19, 2009

   · 

  5 min read
• Cordis Corporation: NEVO(TM) Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus(R) Liberte(R) Stent in Pivotal Clinical Trial

  May 19, 2009

   · 

  1 min read
• Pharm Country

  Schering-Plough Corporation Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males

  May 19, 2009

   · 

  2 min read
• Drug Development

  Janssen, L.P. New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia

  May 19, 2009

   · 

  13 min read
• Medtronic, Inc.'s Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome

  May 19, 2009

   · 

  1 min read